LD-2 disclosure · 2nd Quarter - Report

MASIMO CORPORATION

2nd Quarter (Apr 1 - June 30) · 2022Posted Jul 19, 2022Filing document ↗LDA record ↗

Expenses$60Kself-filed spend

Client

5 issues

Health Issues
Support for the use of medical technology for monitoring of patients taking opioids and the use of technology for withdrawal symptoms, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support for public education on the dangers of opioid induced respiratory depression and monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Remote patient monitoring technology; Medicare coverage and reimbursement; Support for regulatory oversight of antitrust violations/anticompetitive behavior;
LobbyistsCATHERINE MEIER · PAUL ORDAL
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS)
Consumer Issues/Safety/Products
Dangers of reprocessed medical devices
LobbyistsCATHERINE MEIER
TargetedHOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Support for patent reform
LobbyistsCATHERINE MEIER

LD-2 disclosure · 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) · 2022Posted Jul 19, 2022Filing document ↗LDA record ↗

Expenses$60Kself-filed spend

5 issues

Health Issues
Support for the use of medical technology for monitoring of patients taking opioids and the use of technology for withdrawal symptoms, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support for public education on the dangers of opioid induced respiratory depression and monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Remote patient monitoring technology; Medicare coverage and reimbursement; Support for regulatory oversight of antitrust violations/anticompetitive behavior;
LobbyistsCATHERINE MEIER · PAUL ORDAL
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS)
Consumer Issues/Safety/Products
Dangers of reprocessed medical devices
LobbyistsCATHERINE MEIER
TargetedHOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Support for patent reform
LobbyistsCATHERINE MEIER